WOLFGANG SCHILLING

Sanglifehrins A, B, C and D, Novel Cyclophilin-binding Compounds Isolated from Streptomyces sp. A92-308110. I. Taxonomy, Fermentation, Isolation and Biological Activity.

Jean‐Jacques Sanglier, Valérie Quesniaux, THEODOR FEHR et al. · The Journal of Antibiotics · 1999 · 148 citations · Full text

Pharmacy, Biochemistry, Microbiology +6

Sanglifehrins A, B, C and D, Novel Cyclophilin-binding Compounds Isolated from Streptomyces sp. A92-308110. II. Structure Elucidation, Stereochemistry and Physico-chemical Properties.

THEODOR FEHR, Jörg Kallen, Lukas Oberer et al. · The Journal of Antibiotics · 1999 · 104 citations · Full text

Pharmacy, Biochemistry, Microbiology +6

Antascomicins A, B, C, D and E. Novel FKBP12 Binding Compounds from a Micromonospora Strain.

THEODOR FEHR, Jean‐Jacques Sanglier, W. Schüler et al. · The Journal of Antibiotics · 1996 · 63 citations · Full text

Pharmacy, Biochemistry, Pharmacology +3

Intermediates of rifamycin polyketide synthase produced by an Amycolatopsis mediterranei mutant with inactivated rifF gene

Ansgar Stratmann, Christiane Toupet, WOLFGANG SCHILLING et al. · Microbiology · 1999 · 53 citations

Life Sciences, Biochemistry, Molecular Biology +13

New Insights into Rifamycin B Biosynthesis: Isolation of Proansamycin B and 34a-Deoxy-rifamycin W as Early Macrocyclic Intermediates Indicating Two Separated Biosynthetic Pathways.

Ansgar Stratmann, Thomas Schupp, Christiane Toupet et al. · The Journal of Antibiotics · 2002 · 24 citations · Full text

Pharmacy, Biochemistry, Medicinal Chemistry +8